Dec 17 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* U.S. FDA APPROVES REMOVAL OF "NOT FOR HOME USE" LABEL RESTRICTION FOR PLIAGLIS®
* CRESCITA THERAPEUTICS - FDA APPROVED PRIOR APPROVAL SUPPLEMENT FOR PLIAGLIS FOLLOWING MANDATED 6-MONTH REVIEW PROCESS, IN LINE WITH PDUFA DATE